Filtros de búsqueda

Lista de obras de Caroline Seynaeve

11q13 is a susceptibility locus for hormone receptor positive breast cancer

artículo científico publicado en 2012

19p13.1 is a triple-negative-specific breast cancer susceptibility locus

artículo científico publicado en 2012

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

artículo científico publicado en 2014

5-HT3 receptor antagonists, a new approach in emesis: a review of ondansetron, granisetron and tropisetron

artículo científico publicado en 1991

7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium

artículo científico publicado en 2011

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

artículo científico publicado en 2012

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting

artículo científico publicado en 2008

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

artículo científico publicado en 2013

A metastasis of an adenocarcinoma in a BRCA1 mutation carrier, a diagnostic problem not solved by morphology alone

artículo científico publicado en 2004

A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours

artículo científico publicado en 2004

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

artículo científico publicado en 1991

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

artículo científico publicado en 2015

A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships

artículo científico publicado en 2007

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

artículo científico publicado en 2014

Abstract S4-06: HER2 status as predictive marker for AI vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.

artículo científico publicado en 2015

Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support

artículo científico publicado en 1996

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

artículo científico publicado en 2016

Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis

artículo científico publicado en 2011

Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer

artículo científico publicado en 2003

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

artículo científico publicado en 2016

An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2016

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

artículo científico publicado en 2015

Association analysis identifies 65 new breast cancer risk loci.

artículo científico publicado en 2017

Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival

artículo científico publicado en 2010

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

artículo científico publicado en 2012

Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers

artículo científico publicado en 2010

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

artículo científico publicado en 2010

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

article by Xiang Shu et al published 1 October 2018 in International Journal of Epidemiology

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing

artículo científico publicado en 2003

Author Reply: Decision-Making Management of Women with a High Risk of Developing Breast and Ovarian Cancer

artículo científico publicado en 2008

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

artículo científico publicado en 2010

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

artículo científico publicado en 2017

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group

artículo científico publicado en 2013

Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study ⬇️

artículo científico publicado el 19 de noviembre de 2011

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer

article by Jessica P. Gopie et al published 8 December 2012 in Familial Cancer

Body mass index and breast cancer survival: a Mendelian randomization analysis

artículo científico publicado en 2017

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

artículo científico publicado en 2013

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

artículo científico publicado en 2001

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction

artículo científico publicado en 2015

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

artículo científico publicado en 2012

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

artículo científico publicado en 2016

Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling

artículo científico publicado en 1999

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

artículo científico publicado en 2012

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

artículo científico publicado en 2012

CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer

artículo científico publicado en 2013

CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer

artículo científico publicado en 2015

CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

artículo científico publicado en 2013

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

artículo científico publicado en 2011

Chemotherapy in metastasized breast carcinoma

artículo científico publicado el 25 de julio de 1998

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

artículo científico publicado en 2007

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation

artículo científico publicado en 2002

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

artículo científico publicado en 2009

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study

scientific article published on 01 June 2000

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Common germline polymorphisms associated with breast cancer-specific survival

artículo científico publicado en 2015

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2014

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

artículo científico publicado en 2012

Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

artículo científico publicado en 2000

Controlling cancer chemotherapy-induced emesis ⬇️

artículo científico publicado el 18 de octubre de 1991

Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

artículo científico publicado en 2012

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

artículo científico publicado en 2015

Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy

artículo científico publicado en 2007

Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment

artículo científico publicado en 2011

Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature

artículo científico

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

artículo científico publicado en 2007

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

scientific article published on 03 October 2013

Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial.

artículo científico publicado en 2015

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

artículo científico publicado en 2018

Ecthyma gangrenosum caused by Pseudomonas aeruginosa in a patient with astrocytoma treated with chemotherapy

artículo científico publicado en 2010

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk

artículo científico publicado en 2001

Effects of CYP Induction by Rifampicin on Tamoxifen Exposure

artículo científico publicado el 23 de mayo de 2012

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial

artículo científico publicado en 2010

Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis

artículo científico publicado en 2012

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial

artículo científico publicado en 2011

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

artículo científico publicado en 2017

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

artículo científico publicado en 2018

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

artículo científico publicado en 2014

Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

artículo científico publicado en 2017

External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer

artículo científico publicado en 2014

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

artículo científico publicado en 2014

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

artículo científico publicado en 2006

Familial versus Sporadic Breast Cancer: Different Treatments for Similar Tumors?

artículo científico publicado en 2015

Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study

artículo científico publicado en 2005

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

artículo científico publicado en 2016

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

artículo científico publicado en 2016

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

artículo científico publicado en 2015

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

artículo científico publicado en 2020

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

artículo científico publicado en 2016

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

artículo científico publicado en 2014

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

artículo científico publicado en 2013

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium

artículo científico publicado en 2009

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

artículo científico publicado en 2013

GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial design

artículo científico publicado en 2008

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

scientific article published on 06 October 2016

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

artículo científico publicado en 2014

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

artículo científico publicado en 2014

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

artículo científico publicado en 2016

Genome-wide association analysis identifies three new breast cancer susceptibility loci

artículo científico publicado en 2012

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

artículo científico publicado en 2015

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

artículo científico publicado en 2013

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Genome-wide association study of germline variants and breast cancer-specific mortality

artículo científico publicado en 2019

Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial

article

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy

artículo científico publicado en 2011

Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy

artículo científico publicado en 2012

Gynaecological sarcomas

artículo científico publicado en 2007

HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2.

artículo científico

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

artículo científico publicado en 2015

Heterogeneous HER2 gene amplification: impact on patient outcome and a clinically relevant definition

artículo científico publicado en 2011

High satisfaction rates in women after DIEP flap breast reconstruction

artículo científico publicado en 2008

High-dose chemotherapy in adult sarcomas: no standard yet.

artículo científico publicado en 1999

Hypersensitivity reactions to CHIP.

artículo científico publicado en 1990

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

artículo científico publicado en 2014

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

artículo científico publicado en 2016

Identification of novel genetic markers of breast cancer survival

artículo científico publicado en 2015

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers

artículo científico publicado en 2015

Impact of screening for breast cancer in high-risk women on health-related quality of life

artículo científico publicado en 2004

Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment

artículo científico publicado en 2007

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis

artículo científico publicado en 2014

Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy

artículo científico publicado en 2011

Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis

artículo científico publicado en 2012

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

artículo científico publicado en 2015

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy

artículo científico publicado en 2004

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families

artículo científico publicado en 2001

Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair

artículo científico publicado en 2015

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

artículo científico publicado en 2015

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

artículo científico publicado en 2013

Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia

artículo científico

Late effects of adjuvant chemotherapy for breast cancer on fine motor function

artículo científico publicado en 2015

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study

artículo científico publicado en 2003

Long‐term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile ⬇️

artículo científico publicado el 7 de febrero de 2012

Low Dose Methotrexate and Vinblastine, Given Weekly to Patients With Desmoid Tumours, is Associated With Major Toxicity

artículo científico publicado en 2003

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2011

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

scientific article published on 14 January 2014

MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk

artículo científico publicado en 2012

MUTYH gene variants and breast cancer in a Dutch case–control study

artículo científico publicado en 2012

Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study

artículo científico publicado en 2012

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline ⬇️

artículo científico publicado el 12 de julio de 2012

MicroRNA related polymorphisms and breast cancer risk

artículo científico publicado en 2014

Micrometastases or isolated tumor cells and the outcome of breast cancer.

artículo científico publicado en 2009

Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis

article published in 2014

Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls

artículo científico publicado en 2010

Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant

artículo científico publicado en 2016

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

artículo científico publicado en 2017

Most women recover from psychological distress after postoperative complications following implant or DIEP flap breast reconstruction: A prospective long-term follow-up study

artículo científico publicado en 2017

Multidisciplinary treatment of superior sulcus (Pancoast) tumors

artículo científico publicado el 26 de abril de 1997

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study.

artículo científico publicado en 2014

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study

artículo científico publicado en 2009

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy

artículo científico publicado en 2012

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

artículo científico publicado en 2009

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

scientific article published on 11 December 2008

Novel endocrine therapies in breast cancer

artículo científico publicado en 1996

Occult cancer in the fallopian tube in patients with a BRCA-1 germline mutation

artículo científico publicado en 2001

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

artículo científico publicado en 1990

Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatin

artículo científico publicado en 1990

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

artículo científico publicado en 2002

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands

artículo científico publicado en 2013

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2016

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer

artículo científico publicado en 2005

Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine origin

artículo científico publicado en 2009

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

artículo científico publicado en 2017

Passive coping and psychological distress in women adhering to regular breast cancer surveillance

artículo científico publicado en 2007

Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear ⬇️

artículo científico publicado el 22 de febrero de 1991

Patients' preferences for breast reconstruction: a discrete choice experiment

artículo científico publicado en 2010

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

artículo científico publicado en 2009

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer

artículo científico publicado en 1991

Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients

artículo científico publicado en 2000

Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group

artículo científico publicado el 1 de enero de 1992

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

artículo científico publicado en 2001

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr

artículo científico publicado en 2005

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

artículo científico publicado en 2019

Possible consequences of applying guidelines to healthy women with a family history of breast cancer

artículo científico publicado en 2003

Practice guideline 'Diagnostic techniques for soft tissue tumours and treatment of soft tissue sarcomas (revision)'

artículo científico publicado en 2005

Prediction of breast cancer risk based on profiling with common genetic variants

artículo científico publicado en 2015

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

artículo científico publicado en 2000

Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy

artículo científico publicado en 2015

Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families

artículo científico publicado en 2010

Preventive surgical prcedures for inherited risk of breast cancer

artículo científico publicado en 2005

Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy

artículo científico publicado en 2005

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

scientific article published on 17 October 2016

Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients

artículo científico publicado en 2000

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups

artículo científico publicado en 2016

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

artículo científico publicado en 2007

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life

artículo científico publicado en 2007

Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer

artículo científico publicado en 2003

Psychological distress in women at increased risk for breast cancer: the role of risk perception

article by Silvia van Dooren et al published September 2004 in European Journal of Cancer

Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support

artículo científico publicado en 2010

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

artículo científico publicado en 2018

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study ⬇️

artículo científico publicado el 28 de marzo de 2012

RAD51B in Familial Breast Cancer

artículo científico publicado en 2016

Radiation Dose-Response For Risk Of Myocardial Infarction In Breast Cancer Survivors

article published in 2018

Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer ⬇️

artículo científico publicado el 1 de enero de 1991

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue

article

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study

artículo científico publicado en 2014

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer

artículo científico publicado en 2017

Relevant impact of central pathology review on nodal classification in individual breast cancer patients ⬇️

artículo científico publicado el 11 de abril de 2012

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

artículo científico publicado en 2017

Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.

artículo científico publicado en 2009

Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women

artículo científico publicado en 2006

Self‐reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side‐study ⬇️

artículo científico publicado el 23 de febrero de 2011

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2009

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

artículo científico publicado en 2015

Severe akathisia as a side effect of metoclopramide ⬇️

artículo científico publicado el 30 de octubre de 2010

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study ⬇️

artículo científico publicado el 8 de enero de 2013

Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis

artículo científico publicado en 2013

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

artículo científico publicado en 2009

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis

artículo científico publicado en 2013

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

artículo científico publicado en 2014

Survival and prognostic factors in BRCA1-associated breast cancer

artículo científico publicado en 2005

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 ⬇️

artículo científico publicado el 31 de enero de 1998

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

artículo científico publicado en 1999

Tailoring breast cancer therapy to genetic status

artículo científico publicado en 2005

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2013

Targeted therapy: ready for prime time?

artículo científico publicado en 2004

The 5-HT3 receptor antagonist ondansetron re-establishes control in refractory emesis induced by non-cisplatin chemotherapy

artículo científico publicado en 1991

The Distress Thermometer assessed in women at risk of developing hereditary breast cancer

artículo científico publicado en 2009

The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

article

The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study

article

The contribution of self-esteem and self-concept in psychological distress in women at risk of hereditary breast cancer

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy

artículo científico publicado en 2006

The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer

artículo científico publicado en 2010

The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer

The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer

artículo científico publicado en 2010

The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis

artículo científico publicado en 2015

The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas

artículo científico publicado en 2007

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

artículo científico publicado en 2015

The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting

artículo científico publicado en 1999

The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling

artículo científico publicado en 2012

The role of genetic breast cancer susceptibility variants as prognostic factors

artículo científico publicado en 2012

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

artículo científico publicado en 2014

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

artículo científico publicado en 2015

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer

artículo científico publicado en 2016

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer

artículo científico publicado en 2006

Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer

artículo científico publicado en 2014

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

artículo científico publicado en 2004

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases

artículo científico publicado en 2007

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation ⬇️

artículo científico publicado el 1 de mayo de 2003

Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care

artículo científico publicado en 2005

Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial

artículo científico publicado en 2016

Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda